157701-72-9

Usage

Synthesis Reference(s)

Tetrahedron Letters, 37, p. 347, 1996 DOI: 10.1016/0040-4039(95)02169-8

InChI:InChI=1/C7H4FNO3/c8-7-3-6(9(11)12)2-1-5(7)4-10/h1-4H

Upstream product

• 402-67-5 3-fluoro-1-nitrobenzene 
• 88088-95-3 tris(benzotriazol-1-yl)methane 
• 403-24-7 2-fluoro-4-nitrobenzoic acid 
• 660432-43-9 (2-fluoro-4-nitrophenyl)methanol 
• 774239-17-7 2-fluoro-N-methoxy-N-methyl-4-nitrobenzamide 
• 679839-53-3 2-fluoro-4-nitrobenzaldehyde-bis-acetate 

Downstream Products

• 1026163-15-4 2-(2-fluoro-4-nitro-phenyl)-1H-benzoimidazole-5-carboxylic acid 
• 1027429-71-5 2-(2-fluoro-4-nitro-phenyl)-1H-benzoimidazole-5-carboxylic acid pyridin-2-ylamide 
• 1026044-02-9 2-(4-amino-2-fluoro-phenyl)-1H-benzoimidazole-5-carboxylic acid pyridin-2-ylamide 
• 679839-54-4 2-(2,6-dimethylmorpholin-4-yl)-4-nitrobenzaldehyde 
• 777089-27-7 4-amino-2-fluorobenzaldehyde 
• 847257-01-6 2-fluoro-4-nitro-1-vinylbenzene 
• 886978-86-5 C₁₂H₁₅FN₂O₄ 
• 1202518-88-4 2-(2-fluoro-4-nitrophenyl)-1,4,5,6-tetrahydropyrimidine 
• 1224722-43-3 (E)-4-(2-(4-bromobenzylthio)-3-(2-fluoro-4-nitrophenyl)acryloyl)benzoic acid 
• 1142293-21-7 (E)-Ethyl 3-(2-fluoro-4-nitrophenyl)-2-methylacrylate 
• 1244060-83-0 (E)-O-tert-butyl-2-fluoro-4-nitrobenzaldehyde oxime 
• 1244060-76-1 2-fluoro-4-nitrobenzaldehyde oxime 
• 1393679-83-8 C₁₇H₁₅FN₂O₃ 
• 89641-03-2 C₇H₄F₃NO₂ 

Relevant academic research and scientific papers

Discovery, Structure-Activity Relationships, and in Vivo Evaluation of Novel Aryl Amides as Brain Penetrant Adaptor Protein 2-Associated Kinase 1 (AAK1) Inhibitors for the Treatment of Neuropathic Pain

Effective treatment of chronic pain, in particular neuropathic pain, without the side effects that often accompany currently available treatment options is an area of significant unmet medical need. A phenotypic screen of mouse gene knockouts led to the d

Synthesis method of 3-fluoro-5-nitrobenzaldehyde

The invention belongs to the technical field of medical intermediates, and particularly relates to a synthetic method of 3-fluorine -5-nitrobenzaldehyde. A compound A is used as an initial raw material, a compound B is generated in a concentrated sulfuric

BIS(TRIMETHYLSILYL)PHENYL COMPOUND OR SALT THEREOF, AND USE THEREOF

The present invention provides a compound that exhibits an excellent antitumor effect and reduces side effects, such as skin disorders, of the existing retinoid by selectively activating on the nuclear receptor RARα, thereby possibly producing significant

Synthesis, larvicidal activity, and SAR studies of new benzoylphenylureas containing oxime ether and oxime ester group

A series of new structural benzoylphenylureas (BPUs) containing oxime ether and oxime ester group were designed and synthesized. The larvicidal activities against Oriental armyworm and mosquito of these benzoylphenylureas were evaluated and the result of bioassay displayed specific structure-activity relationship (SAR). Most of the compounds exhibited excellent larvicidal activities against Oriental armyworm and mosquito. Interestingly, some compounds showed different structure-activity relationship towards diamondback moth, beet armyworm, and corn borer although three tested insects all belong to the same insect order.

ARYLOXY-SUBSTITUTED BENZIMIDAZOLE DERIVATIVES

A glucokinase activator is provided; and a treatment and/or a preventive for diabetes, or a treatment and/or a preventive for diabetes such as retinopathy, nephropathy, neurosis, ischemic cardiopathy, arteriosclerosis, and further a treatment and/or a preventive for obesity are provided. The invention relates to a compound of a formula (I): [wherein R1 and R2 represent a hydrogen, etc.; R3 represents a hydrogen atom, a halogen atom, etc.; R4 each independently represents a hydrogen atom, a lower alkyl group, etc.; Q represents a carbon atom, a nitrogen atom or a sulfur atom (the sulfur atom may be mono- or di-substituted with an oxo group); R5 and R6 each represent a hydrogen atom, a lower alkyl group, etc.; X1, X2, X3 and X4 each independently represent a carbon atom or a nitrogen atom; Z represents an oxygen atom, a sulfur atom or a nitrogen atom; Ar represents an aryl or heteroaryl group optionally mono to tri-substituted with a group selected from the substituent group β; ring A represents a 5- or 6-membered nitrogen-containing heteroaromatic group; m indicates an integer of from 1 to 6; n indicates an integer of from 0 to 3; p indicates an integer of from 0 to 2 (provided that at least two of X1 to X4 are carbon atoms); q indicates 0 or 1] or its pharmaceutically-acceptable salt, which has an effect of glucokinase activation and is useful as a treatment for diabetes.

ANTIMICROBIAL [3.1.0] BICYCLOHEXYLPHENYL-OXAZOLIDINONE DERIVATIVES AND ANALOGUES

The present invention provides certain [3.1.0] bicyclic oxazolidinone derivatives of Formula (I) or pharmaceutically acceptable salts or prodrugs thereof that are antibacterial agents, pharmaceutical compositions containing them, methods for their use, an

TRICYCLIC TETRAHYDROQUINOLINE ANTIBACTERIAL AGENTS

The invention includes tetrahydroquinoline and related compounds of formula (I), and pharmaceutical compositions thereof, that exhibit useful antibacterial activity against a wide range of human and veterinary pathogens.

para-Formylation of nitroarenes via vicarious nucleophilic substitution of hydrogen with tris(benzotriazol-1-yl)methane

Reaction of nitroarenes 1 with tris(benzotriazol-1-yl)methyl 2 anion afforded para-bis(benzotriazol-1-yl)methylated products 3 which, upon treatment with zinc bromide and hydrochloric acid, yielded the corresponding p-nitroarylaldehydes 4 in good yields.